Back

Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Shedding light on transthyretin cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Daud Mutahar

Gold Coast Hospital And Health Service, Gold Coast (Australia)

7 More presentations in this session

Presentation thumbnail
Predictors and outcomes of amyloid cardiomyopathy caused by transthyretin V30 mutation
Doctor M. Pereira Santos (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Nutritional status and its impact on transthyretin cardiac amyloidosis: unraveling connection
Mrs P. Lujan Garcia (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment
Doctor V. Castiglione (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Lifetime physical and athletic activity as novel risk factors in the development of wild-type transthyretin amyloid cardiomyopathy - a multicenter cohort study
Doctor N. Schwegel (Graz, AT)
Abstract Slides Video
Presentation thumbnail
A review of routine bone scintigraphy reports for identification of incidental myocardial tracer uptake indicating cardiac amyloidosis
Mr D. Hutt (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Shedding light on transthyretin cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence and prognostic impact of aortic stenosis in wild-type transthyretin cardiac amyloidosis
thumbnail
Congress Presentation
Long-term outcomes in patients with dual pathology aortic stenosis and cardiac amyloidosis referred for valve intervention
thumbnail
Congress Presentation
Association of cardiac amyloidosis with periprocedural complications in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources